Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin

Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin

Abstract Introduction The Alzheimer's disease (AD) process is likely initiated many years before clinical onset. Biomarkers of preclinical disease are critical for the development of disease‐modifying or even preventative therapies. Current biomarkers for early disease, including cerebrospinal...

Full description

Bibliographic Details
Main Authors: Eva Carro, Fernando Bartolomé, Félix Bermejo‐Pareja, Alberto Villarejo‐Galende, José Antonio Molina, Pablo Ortiz, Miguel Calero, Alberto Rabano, José Luis Cantero, Gorka Orive
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Noninvasive biomarkers
Saliva
Lactoferrin
Alzheimer's disease
Mild cognitive impairment
Dementia
Online Access:https://doi.org/10.1016/j.dadm.2017.04.002

Internet

https://doi.org/10.1016/j.dadm.2017.04.002

Similar Items